Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6512)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 21, 2022 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gu B, Venkatesh K, Williams AJ, Ng W, Corte C, Gholamrezaei A, Ghaly S, Xuan W, Paramsothy S, Connor S. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease. World J Gastroenterol 2022; 28(23): 2597-2608 [PMID: 35949350 DOI: 10.3748/wjg.v28.i23.2597] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i23/2597.htm |
| Number | Citing Articles |
| 1 |
Alyssa M. Parian, Megan Obi, Phillip Fleshner, David A. Schwartz. Management of Perianal Crohn's Disease. American Journal of Gastroenterology 2023; 118(8): 1323 doi: 10.14309/ajg.0000000000002326
|
| 2 |
Kailei Ding, Jiayuan Kong, Ling Li, Florin M. Selaru, Alyssa Parian, Hai-Quan Mao. Emerging Therapeutic Targets and Drug Delivery Approaches in IBD. Advances in Pharmacology 2024; 101: 159 doi: 10.1016/bs.apha.2024.10.013
|
| 3 |
Elise M. Meima - van Praag, Marte A.J. Becker, Kyra L. van Rijn, Karin A.T.G.M. Wasmann, Jaap Stoker, Geert R.A.M. D'Haens, Cyriel Y. Ponsioen, Krisztina B. Gecse, Marcel G.W. Dijkgraaf, Antonino Spinelli, Silvio Danese, Willem A. Bemelman, Christianne J. Buskens. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trial. eClinicalMedicine 2023; 61: 102045 doi: 10.1016/j.eclinm.2023.102045
|
| 4 |
Hajime Kayano, Ken-Ichi Okada, Seiichiro Yamamoto, Kazuo Koyanagi. Establishment of a surveillance program for anal cancer in Crohn's disease. World Journal of Gastroenterology 2024; 30(45): 4844-4849 doi: 10.3748/wjg.v30.i45.4844
|
| 5 |
Dongxing Cao, Keyu Qian, Ying Zhao, Jie Hong, Haoyan Chen, Xiaohui Wang, Nailin Yang, Cheng Zhang, Jingkai Cao, Keyu Jia, Guangyu Wu, Mingming Zhu, Jun Shen, Ye Zhang, Zhe Cui, Zheng Wang. Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn’s Disease. Journal of Crohn's and Colitis 2023; 17(4): 580 doi: 10.1093/ecco-jcc/jjac171
|
| 6 |
Jiayin Yao, Heng Zhang, Tao Su, Xiang Peng, Junzhang Zhao, Tao Liu, Wei Wang, Pinjin Hu, Min Zhi, Min Zhang. Ustekinumab Promotes Radiological Fistula Healing in Perianal Fistulizing Crohn’s Disease: A Retrospective Real-World Analysis. Journal of Clinical Medicine 2023; 12(3): 939 doi: 10.3390/jcm12030939
|
| 7 |
Saher‐Zahra Khan, Andrea Arline, Kate M. Williams, Matthew J. Lee, Emily Steinhagen, Sharon L. Stein. The use of core descriptors from the ENiGMA code study in recent literature: a systematic review. Colorectal Disease 2024; 26(3): 428 doi: 10.1111/codi.16893
|
| 8 |
Konstantinos Papamichael, Andrea Centritto, Lucas Guillo, Jessica Hier, Zachary Sherman, Adam S. Cheifetz, Dorsaf Zoghlami, Sivan Harnik, Lieven Mulders, Nikolaos Kamperidis, Sylvia Sidky, Alexandra Bruss, Tina Deyhim, Mark A. Samaan, Andres J. Yarur, Byron P. Vaughn, Naila Arebi, Krisztina B. Gecse, Bella Ungar, Xavier Roblin, Stephane Paul, Robert Battat, Waqqas Afif, Laurent Peyrin-Biroulet, Peter M. Irving. Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn’s Disease. Clinical Gastroenterology and Hepatology 2024; 22(10): 2134 doi: 10.1016/j.cgh.2024.04.005
|
| 9 |
Tatiana Pacheco, Sara Monteiro, Luísa Barros, Jorge Silva. Perianal disease in inflammatory bowel disease: Broadening treatment and surveillance strategies for anal cancer. World Journal of Gastroenterology 2024; 30(28): 3373-3385 doi: 10.3748/wjg.v30.i28.3373
|
| 10 |
Luke N. Hanna, Sulak Anandabaskaran, Nusrat Iqbal, Jeroen Geldof, Jean-Frédéric LeBlanc, Anders Dige, Lilli Lundby, Séverine Vermeire, André D’Hoore, Bram Verstockt, Gabriele Bislenghi, Danny De Looze, Triana Lobaton, Dirk Van de Putte, Antonino Spinelli, Michele Carvello, Silvio Danese, Christianne J. Buskens, Krisztina Gecse, Roel Hompes, Marte Becker, Jarmila van der Bilt, Wilhelmus Bemelman, Shaji Sebastian, Gordan Moran, Amy L. Lightner, Serre-Yu Wong, Jean-Frédéric Colombel, Benjamin L. Cohen, Stefan Holubar, Nik S. Ding, Cori Behrenbruch, Kapil Sahnan, Ravi Misra, Phillip Lung, Ailsa Hart, Phil Tozer. Perianal Fistulizing Crohn’s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care. Clinical Gastroenterology and Hepatology 2024; doi: 10.1016/j.cgh.2024.06.047
|
| 11 |
Laura Maas, Ruiyi Gao, Vivy Cusumano, Ellen Spartz, Reezwana Chowdhury, Mahesh Krishna, Mark Lazarev, Joanna Melia, Florin Selaru, Sowmya Sharma, Berkeley Limketkai, Alyssa Parian. Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn’s Perianal Fistulae. Digestive Diseases and Sciences 2023; 68(10): 3994 doi: 10.1007/s10620-023-08060-7
|
| 12 |
E. F. Miranda, R. B. Nones, F. B. Baraúna, G. de Nardi Marçal, M. Olandoski, T. P. de Moraes, P. G. Kotze. Infliximab serum concentrations and disease activity in perianal fistulizing Crohn’s disease: a cross-sectional study. Techniques in Coloproctology 2024; 28(1) doi: 10.1007/s10151-024-02953-z
|